Table 1. Correlation of HOXB9 expression with clinicopathologic characteristics of colon cancer patients.
Characteristics | HOXB9 expression | P | |||
---|---|---|---|---|---|
Low (n=63) | High (n=65) | ||||
Age (year) | |||||
≤60 | 27 | 30 | 0.71 | ||
>60 | 36 | 35 | |||
Sex | |||||
Female | 37 | 31 | 0.21 | ||
Male | 26 | 34 | |||
Tumor location | |||||
Ascending colon | 14 | 19 | 0.44 | ||
Transverse colon | 18 | 13 | |||
Descending colon | 11 | 16 | |||
Sigmoid colon | 20 | 17 | |||
pT (invasion depth) | |||||
T1+T2 | 17 | 13 | 0.35 | ||
T3+T4 | 46 | 52 | |||
pN (lymph node metastasis) | |||||
N0 | 18 | 8 | 0.02 | ||
N1-N2 | 45 | 57 | |||
pM (distant metastasis) | |||||
M0 | 61 | 54 | 0.01 | ||
M1 | 2 | 11 | |||
TNM stage | |||||
I+II | 16 | 8 | 0.06 | ||
III+IV | 47 | 57 | |||
Differentiation grade | |||||
Well | 2 | 4 | 0.54 | ||
Moderate | 54 | 56 | |||
Poor | 5 | 2 | |||
Mucinous | 2 | 3 | |||
Preoperative CEA level | |||||
≤5 ng/mL | 33 | 37 | 0.61 | ||
>5 ng/mL | 30 | 28 |
HOXB9, homeobox B9; CEA, carcinoembryonic antigen.